These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27558943)

  • 21. Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness.
    Solberg LI; Maciosek MV; Edwards NM
    Am J Prev Med; 2008 Feb; 34(2):143-152. PubMed ID: 18201645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies in primary healthcare to implement early identification of risky alcohol consumption: why do they work or not? A qualitative evaluation of the ODHIN study.
    Keurhorst M; Heinen M; Colom J; Linderoth C; Müssener U; Okulicz-Kozaryn K; Palacio-Vieira J; Segura L; Silfversparre F; Słodownik L; Sorribes E; Laurant M; Wensing M
    BMC Fam Pract; 2016 Jun; 17():70. PubMed ID: 27267887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic modelling of a public health programme for fall prevention.
    Farag I; Howard K; Ferreira ML; Sherrington C
    Age Ageing; 2015 May; 44(3):409-14. PubMed ID: 25523025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production Losses Associated with Alcohol-Attributable Mortality in the European Union.
    Łyszczarz B
    Int J Environ Res Public Health; 2019 Sep; 16(19):. PubMed ID: 31546662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
    Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
    Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis.
    Chisholm D; Rehm J; Van Ommeren M; Monteiro M
    J Stud Alcohol; 2004 Nov; 65(6):782-93. PubMed ID: 15700517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of forty health interventions in Guinea.
    Jha P; Bangoura O; Ranson K
    Health Policy Plan; 1998 Sep; 13(3):249-62. PubMed ID: 10187595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How much might a society spend on life-saving interventions at different ages while remaining cost-effective? A case study in a country with detailed data.
    Kvizhinadze G; Wilson N; Nair N; McLeod M; Blakely T
    Popul Health Metr; 2015; 13():15. PubMed ID: 26155199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic Burden of Bladder Cancer Across the European Union.
    Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
    Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cost-effectiveness of addiction care].
    Suijkerbuijk AW; van Gils PF; Greeven PG; de Wit GA
    Tijdschr Psychiatr; 2015; 57(7):498-507. PubMed ID: 26189418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of alcohol in the management of hypertension in patients in European primary health care practices - a survey in the largest European Union countries.
    Rehm J; Prieto JA; Beier M; Duhot D; Rossi A; Schulte B; Zarco J; Aubin HJ; Bachmann M; Grimm C; Kraus L; Manthey J; Scafato E; Gual A
    BMC Fam Pract; 2016 Sep; 17(1):130. PubMed ID: 27608770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
    Burns R; Leal J; Sullivan R; Luengo-Fernandez R
    Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.